AtulChawlaMDFACP(He/Him)
Cardiology • West Des Moines, IAInterventional Cardiology, Peripheral Endovascular Interventional Cardiology
Structural Heart Cardiologist
Dr. Chawla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5880 University Ave
West Des Moines, IA 50266Phone+1 515-633-3600Fax+1 515-288-0840
Summary
- Dr. Atul Chawla is a cardiologist in West Des Moines, IA and is affiliated with multiple hospitals in the area, including UnityPoint Health - Iowa Methodist Medical Center and MercyOne Des Moines Medical Center. He received his medical degree from Christian Medical College Ludhiana and has been in practice 27 years. He specializes in interventional cardiology and is experienced in general cardiology, cardiac catheterization, peripheral vascular disease
Education & Training
Creighton University School of Medicine (Omaha)Fellowship, Cardiovascular Disease, 1997 - 2000- Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 1994 - 1997
- Creighton University School of MedicineInternship, Transitional Year, 1993 - 1994
Christian Medical College LudhianaClass of 1990
Certifications & Licensure
IA State Medical License 1996 - 2026
SC State Medical License 2004 - 2004- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 3 citationsQuality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.Neal S Kleiman, Nicolas M Van Mieghem, Michael J Reardon, Hemal Gada, Mubashir Mumtaz
JACC. Cardiovascular Interventions. 2024-04-22 - 58 citations3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.John K Forrest, G Michael Deeb, Steven J Yakubov, Hemal Gada, Mubashir A Mumtaz
Journal of the American College of Cardiology. 2023-05-02 - 1 citationsImpact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis.Saki Ito, Roger Laham, Vuyisile T Nkomo, John K Forrest, Michael J Reardon
Open Heart. 2023-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
